who cannot take glp-1 Some people weight loss medication, specifically injectable medication! , based medications are contraindicated in patients with a personal or family history of medullary thyroid GLP-1 has changed the conversation

A five-year experiment reportedly aims to expand access to blockbuster GLP1 drugs for obesity, something advocates have sought for years

This bundle features our High-Potency Multi, formulated to address common nutrient deficiencies, and our Dual-Action Probiotic, which combines a clinically-studied probiotic strain, prebiotic fibre, and ginger to promote digestive comfort

Novo Nordisks challenge to Regen Doctors promotional claims for compounded semaglutide led the telehealth clinic to voluntarily withdraw its superiority and safety claims.

Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide

Millions of Americans have turned to cheaper, compounded versions of Ozempic and Wegovy

Drugs that target glucagon-like peptide 1 (GLP-1) have gained lots of attention for their potential health benefits